Ping An Healthcare and Technology Company Limited
HKEX:1833.HK
11.56 (HKD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Revenue
| 4,673.562 | 6,159.821 | 7,334.214 | 6,865.987 | 5,065.429 | 3,337.849 | 1,868.021 | 601.494 | 278.69 |
Cost of Revenue
| 3,165.049 | 4,475.129 | 5,627.353 | 5,001.573 | 3,894 | 2,425.911 | 1,255.951 | 347.915 | 167.923 |
Gross Profit
| 1,508.513 | 1,684.692 | 1,706.861 | 1,864.414 | 1,171.429 | 911.938 | 612.07 | 253.579 | 110.767 |
Gross Profit Ratio
| 0.323 | 0.273 | 0.233 | 0.272 | 0.231 | 0.273 | 0.328 | 0.422 | 0.397 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 300.6 | 100.3 |
General & Administrative Expenses
| 1,480.884 | 1,748.35 | 1,846.413 | 1,017.083 | 1,075.307 | 994.706 | 710.665 | 461.058 | 251.474 |
Selling & Marketing Expenses
| 835.796 | 1,105.372 | 1,756.828 | 1,586.627 | 1,206.673 | 1,238.451 | 723.556 | 781.079 | 178.558 |
SG&A
| 2,316.68 | 2,853.722 | 3,603.241 | 2,603.71 | 2,281.98 | 2,233.157 | 1,434.221 | 1,242.137 | 430.032 |
Other Expenses
| 13.238 | -6.516 | -9.291 | -5.399 | 2.245 | -0.767 | -3.907 | -2.502 | -0.32 |
Operating Expenses
| 2,206.374 | 2,587.614 | 3,597.081 | 3,047.811 | 2,161.211 | 2,212.651 | 1,420.191 | 1,233.919 | 429.417 |
Operating Income
| -575.26 | -1,093.727 | -1,838.872 | -681.632 | -1,069.375 | -1,109.499 | -996.425 | -740.045 | -323.103 |
Operating Income Ratio
| -0.123 | -0.178 | -0.251 | -0.099 | -0.211 | -0.332 | -0.533 | -1.23 | -1.159 |
Total Other Income Expenses Net
| 243.367 | 486.033 | 315.265 | -259.716 | 335.246 | 388.836 | -193.114 | 222.125 | -5.058 |
Income Before Tax
| -331.893 | -607.694 | -1,523.607 | -941.348 | -734.129 | -911.877 | -1,001.235 | -758.215 | -323.708 |
Income Before Tax Ratio
| -0.071 | -0.099 | -0.208 | -0.137 | -0.145 | -0.273 | -0.536 | -1.261 | -1.162 |
Income Tax Expense
| 2.965 | 3.41 | 15.792 | 7.155 | 12.587 | 1.178 | 0.408 | -222.125 | 5.242 |
Net Income
| -322.594 | -607.569 | -1,538.183 | -948.478 | -733.86 | -911.662 | -1,001.643 | -758.215 | -323.708 |
Net Income Ratio
| -0.069 | -0.099 | -0.21 | -0.138 | -0.145 | -0.273 | -0.536 | -1.261 | -1.162 |
EPS
| -0.3 | -0.56 | -1.39 | -0.92 | -0.73 | -0.97 | -0.94 | -0.71 | -0.3 |
EPS Diluted
| -0.3 | -0.56 | -1.39 | -0.92 | -0.73 | -0.97 | -0.94 | -0.71 | -0.3 |
EBITDA
| -243.821 | -1,020.211 | -1,762.638 | -605.199 | -1,005.334 | -895.354 | -921.373 | -729.267 | -312.887 |
EBITDA Ratio
| -0.052 | -0.166 | -0.24 | -0.088 | -0.198 | -0.268 | -0.493 | -1.212 | -1.123 |